Finance

Lists
Why is 600521 up 2.19%?
Dive Deeper
600521:SHA
Zhejiang Huahai Pharmaceutical Co., Ltd.
CNÂ¥16.34
+2.19%
(+0.35) 1D
Sep 30, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600521...
Open
CNÂ¥15.97
High
CNÂ¥16.46
Low
CNÂ¥15.89
Mkt. cap
24.47B
Avg. vol.
25.14M
Volume
21.24M
Dividend
0.61%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
38.42
52-wk high
CNÂ¥21.55
52-wk low
CNÂ¥13.73
EPS
CNÂ¥0.43
Shares outstanding
1.25B
No. of employees
9K
Open
CNÂ¥15.97
High
CNÂ¥16.46
Low
CNÂ¥15.89
Mkt. cap
24.47B
Avg. vol.
25.14M
Volume
21.24M
Dividend
0.61%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
38.42
52-wk high
CNÂ¥21.55
52-wk low
CNÂ¥13.73
EPS
CNÂ¥0.43
Shares outstanding
1.25B
No. of employees
9K
News stories
From web sources and news partners
About Zhejiang Huahai Pharmaceutical Co., Ltd.
CEO-
Employees8.8K
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitehuahaipharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.89B
2.18B
2.34B
2.58B
Cost of goods sold
743.42M
1.13B
988.64M
1.07B
Cost of revenue
743.42M
1.13B
988.64M
1.07B
Research and development expenses
306.29M
399.64M
218.54M
244.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
766.84M
703.66M
810.07M
756.82M
Operating expense
1.02B
1.15B
1.04B
1.03B
Total operating expenses
1.76B
2.28B
2.03B
2.11B
Operating income
129.57M
-104.23M
308.31M
469.54M
Other non operating income
-16.70M
14.72M
-46.77M
44.96M
EBT including unusual items
6.30M
-105.28M
444.33M
457.70M
EBT excluding unusual items
70.67M
-177.11M
447.80M
336.35M
Income tax expense
37.52M
41.32M
45.99M
88.96M
Effective tax rate
596.03%
-39.25%
10.35%
19.44%
Other operating expenses
-36.90M
51.48M
-3.20M
39.10M
Net income
-29.13M
-113.96M
404.18M
366.73M
Net profit margin
-1.54%
-5.23%
17.31%
14.23%
Earnings per share
-
-
-
-
Interest and investment income
23.14M
6.97M
249.37M
-
Interest expense
-59.24M
-58.06M
-63.11M
-83.05M
Net interest expenses
-36.10M
-51.09M
186.27M
-83.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
350.99M
138.33M
550.87M
733.35M
Gain or loss from assets sale
-14.07K
-943.00
-
-23.33M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps